Andrew Horne

No ORCID on file · 11 papers in corpus · active 2012-2025

Study types

  • article 5
  • peer-review 4
  • other 1
  • review 1

Condition tags

  • endometriosis 8
  • mesh:D004715 2
  • chronic_pelvic_pain 2
  • infertility 2
  • mesh:D017699 1
  • adenomyosis 1
article 2025
Exploring the value of a well-established conditioned pain modulation paradigm in women: a Translational Research in Pelvic Pain (TRiPP) study
Frontiers in pain research (Lausanne, Switzerland) ·doi:10.3389/fpain.2025.1439563

Background Conditioned pain modulation (CPM) is considered a human proxy for descending inhibitory pain pathways. However, there is wide variation in the CPM response described in the literature and ongoing debate about its utility. Methods…

other 2025
Personalized Estimation of Fatigue in Endometriosis Using Wrist-Worn Actigraphy Data and Hierarchical Bayesian Modeling
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference ·doi:10.1109/EMBC58623.2025.11253432

Endometriosis is a common chronic condition associated with debilitating pain and fatigue. Wearable technology has the potential to improve symptom monitoring in endometriosis where symptom severity has been traditionally evaluated through …

review 2025
The First Lugano Workshop on the role of adenomyosis in ART
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2024.104444

Adenomyosis is an important clinical condition with uncertain prevalence, and clinical focus on adenomyosis in patients undergoing assisted reproductive technology (ART) has increased during recent years. Recognizing the limited clinical kn…

article 2025
Transforming Endometriosis Care: Interview with Andrew Horne
·doi:10.33590/emjreprohealth/dhpo8497
peer-review 2024
Reviewer #1 (Public review): Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgesia, and rescues mice from a negative behavioural phenotype in experimental endometriosis
·doi:10.7554/elife.99226.2.sa2

Endometriosis is a common and debilitating neuro-inflammatory disorder that is associated with chronic pain. Definitive diagnosis is based on the presence of endometrial-like tissue (lesions) in sites outside the uterus. Kynurenine monooxyg…

peer-review 2024
Reviewer #1 (Public Review): Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgia, and rescues mice from a negative behavioural phenotype in experimental endometriosis
·doi:10.7554/elife.99226.1.sa1

Endometriosis is a common and debilitating neuro-inflammatory disorder that is associated with chronic pain. Definitive diagnosis is based on the presence of endometrial-like tissue (lesions) in sites outside the uterus. Kynurenine monooxyg…

peer-review 2024
Reviewer #2 (Public review): Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgesia, and rescues mice from a negative behavioural phenotype in experimental endometriosis
·doi:10.7554/elife.99226.2.sa1

Endometriosis is a common and debilitating neuro-inflammatory disorder that is associated with chronic pain. Definitive diagnosis is based on the presence of endometrial-like tissue (lesions) in sites outside the uterus. Kynurenine monooxyg…

peer-review 2024
Reviewer #2 (Public Review): Kynurenine monooxygenase blockade reduces endometriosis-like lesions, improves visceral hyperalgia, and rescues mice from a negative behavioural phenotype in experimental endometriosis
·doi:10.7554/elife.99226.1.sa0

Endometriosis is a common and debilitating neuro-inflammatory disorder that is associated with chronic pain. Definitive diagnosis is based on the presence of endometrial-like tissue (lesions) in sites outside the uterus. Kynurenine monooxyg…

article 2018
GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol
·doi:10.60692/6nvwt-mjd92

Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and treatment is …

article 2016
ORIGINAL ARTICLE Gynaecology The burden of endometriosis: costs
article 2012
The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres
Human Reproduction ·doi:10.1093/humrep/des073

BACKGROUND: This study aimed to calculate costs and health-related quality of life of women with endometriosis-associated symptoms treated in referral centres. METHODS: A prospective, multi-centre, questionnaire-based survey measured costs …